Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2.0) for stroke prevention in atrial fibrillation.
CONCLUSIONS: This decision support tool can help optimise the use of antithrombotic therapy in patients with AF by considering risk versus benefit profiles and rationalising treatment selection.
PMID: 28070883 [PubMed - as supplied by publisher]
Source: Cardiology Journal - Category: Cardiology Authors: Wang Y, Bajorek B Tags: Cardiol J Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Computers | Coumadin | Heart | Pradaxa | Stroke | Study | Teaching | Teaching Hospitals | Universities & Medical Training | Vitamins | Warfarin